SBSanne Henrieke Booij

Sanne Henrieke Booij

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sanne Henrieke Booij has a total of 111 co-authors. Here are the top co-authors by number of shared publications:

  • Peter de Jonge

    University of Groningen, Groningen, The Netherlands

    10 shared publications
  • Marieke Wichers

    Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion Regulation, University Medical Center Groningen, University of Groningen

    8 shared publications
  • Johanna T. W. Wigman

    University Medical Centre Groningen: Universitair Medisch Centrum Groningen

    7 shared publications
  • Albertine J. Oldehinkel

    Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

    6 shared publications
  • Harriëtte Riese

    University Medical Center Groningen, University of Groningen

    6 shared publications
  • Elisabeth H. Bos

    University of Groningen, University Medical Center Groningen, Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion regulation (ICPE), CC72, P.O. Box 30.001, 9700 RB Groningen, The Netherlands; Department of Developmental Psychology, University of Groningen, Grote Kruisstraat 2/1, 9712 TS Groningen, The Netherlands

    5 shared publications

Latest Publications

  • Open Access

    Experiences of people in specialist mental healthcare participating in a multidomain lifestyle intervention: a qualitative study in a transdiagnostic sample

    by Charlie Schillemans, Harm Jan Rogier Hoenders, Stijn Crutzen, Esther Steffek, Sanne Henrieke Booij, Stynke Castelein

  • Open Access

    Positive affect as a buffer in the daily relationship between stress and psychotic experiences across the psychosis continuum

    by Merel Karlijn Muller, Johanna T.W. Wigman, Sanne H. Booij, David van Den Berg, Robert A. Schoevers, Lorna Staines, Sara van der Tuin, Larisa Morosan

    Background: There is growing interest in potential protective factors that may attenuate the impact of psychotic experiences (PEs), but research is still scarce. The present study investigates contemporaneous and temporal associations between daily reports of experienced stress and PEs in individuals at different early risk stages of psychosis, focusing on the possible moderating role of positive affect (PA) in these relationships (within-person moderation). Second, the buffering effect of PA differs across early risk stages (between-person moderation). Methods: This study used 90-day daily diary data from 96 individuals allocated into 4 subgroups reflecting increasing psychosis risk: increased psychometric risk without current symptoms (subgroup 1; n = 25), low risk (subgroup 2; n = 27), mild risk (subgroup 3; n = 24), and ultra-high risk (subgroup 4; n = 20). Multilevel models, including double and triple interaction testing, applied to examine associations between experienced stress, PEs, and PA, and to compare these associations across subgroups. Results: Experienced stress showed a significant contemporaneous effect on PEs, which was stronger in subgroup 4 than in other subgroups and stronger in subgroup 3 compared to subgroup 1. PA significantly moderated the contemporaneous effect of experienced stress on PEs; this moderating effect did not differ between subgroups. No significant temporal effect of experienced stress on PEs was found, nor was this effect moderated by either PA or subgroups. Conclusions: Experienced stress is associated with PEs contemporaneously among individuals in early risk stages, and PA buffers this association, underscoring PA as a potentially important protective factor.

  • Open Access

    Better Safe Than Sorry? Risks and Benefits of Neuroticism in Adolescence

    by Larissa Lucia Wieczorek, Eva Bleckmann, Solomiia Myroniuk, Bertus F. Jeronimus, Sanne Booij, Jenny Wagner, Albertine Oldehinkel

    Neuroticism is known for detrimental outcomes, but it may also serve beneficial functions in adolescence, where avoiding and protecting oneself from threats becomes crucial. We examined potential benefits of neuroticism based on longitudinal data of two samples of Dutch adolescents, one population (n = 2229, 51% female) and one clinic-referred (n = 543, 34% female) sample. Neuroticism was measured with parent-ratings of the temperament dimensions fear and frustration and used to predict a diverse set of outcomes in the domains lifestyle choices (e.g., substance abuse) and social resources (e.g., social skills) between ages 11 to 19. High neuroticism conveyed heightened risk but four key observations refine this picture: (1) higher fear related to more social skills and prosocial behavior among adolescents in the clinic-referred sample; (2) fear generally related to fewer risks than frustration; (3) controlling for childhood adversity (e.g., low socioeconomic status, parental divorce) removed links between fear and most detrimental outcomes; (4) both fear and frustration were consistently associated with parent-rated social behavior problems, while other associations varied across neuroticism scales and measurement points. Altogether, we provide initial evidence that, under certain conditions, neuroticism can be beneficial in adolescence, especially among vulnerable individuals and in the social domain.

  • Open Access

    Using daily diary data to examine the period prior to a suicide attempt: An observational single-case study

    by Daniel Núñez, Esdras Raposo de Almeida, Arnout C. Smit, Evelien Snippe, Merel K. Muller, David van Den Berg, Yuan-Pang Wang, Wim Veling, Sanne H. Booij, Johanna T.W. Wigman

  • Open Access

    Externally validated clinical prediction models for estimating treatment outcomes for patients with a mood, anxiety or psychotic disorder: systematic review and meta-analysis

    by Desi G. Burghoorn, Sanne H. Booij, Robert A. Schoevers, Harriëtte Riese

    Background: Suboptimal treatment outcomes contribute to the high disease burden of mood, anxiety or psychotic disorders. Clinical prediction models could optimise treatment allocation, which may result in better outcomes. Whereas ample research on prediction models is performed, model performance in other clinical contexts (i.e. external validation) is rarely examined. This gap hampers generalisability and as such implementation in clinical practice. Aims: Systematically appraise studies on externally validated clinical prediction models for estimated treatment outcomes for mood, anxiety and psychotic disorders by (1) reviewing methodological quality and applicability of studies and (2) investigating how model properties relate to differences in model performance. Method: The review and meta-analysis protocol was prospectively registered with PROSPERO (registration number CRD42022307987). A search was conducted on 8 November 2021 in the databases PubMED, PsycINFO and EMBASE. Random-effects meta-analysis and meta-regression were conducted to examine between-study heterogeneity in discriminative performance and its relevant influencing factors. Results: Twenty-eight studies were included. The majority of studies (n = 16) validated models for mood disorders. Clinical predictors (e.g. symptom severity) were most frequently included (n = 25). Low methodological and applicability concerns were found for two studies. The overall discrimination performance of the meta-analysis was fair with wide prediction intervals (0.72 [0.46; 0.89]). The between-study heterogeneity was not explained by number or type of predictors but by disorder diagnosis. Conclusions: Few models seem ready for further implementation in clinical practice to aid treatment allocation. Besides the need for more external validation studies, we recommend close examination of the clinical setting before model implementation.


  • Open Access

    Fractal motor activity during wakefulness and sleep: a window into depression recency and symptom recurrence

    by O. Minaeva, H. Riese, S. H. Booij, F. Lamers, E. J. Giltay, F. A. J. L. Scheer, K. Hu

    Background: Motor activity fluctuations in healthy adults exhibit fractal patterns characterized by consistent temporal correlations across wide-ranging time scales. However, these patterns are disrupted by aging and psychiatric conditions. This study aims to investigate how fractal patterns vary across the sleep–wake cycle, differ based on individuals' recency of depression diagnosis, and change before and after a depressive episode.Methods: Using actigraphy from two cohorts (n = 378), we examined fractal motor activity patterns both between individuals without depression and with varying recencies of depression and within individuals before and after depressive symptom recurrence. To evaluate fractal patterns, we quantified temporal correlations in motor activity fluctuations across different time scales using a scaling exponent, α. Linear mixed models were utilized to assess the influence of the sleep–wake cycle, (recency of) depression, and their interaction on α.Results: Fractal activity patterns in all individuals varied across the sleep–wake cycle, showing stronger temporal correlations during wakefulness (larger α = 1.035 ± 0.003) and more random activity fluctuations during sleep (smaller α = 0.784 ± 0.004, p < 0.001). This sleep–wake difference was reduced in recently depressed individuals (1–6 months), leading to larger α during sleep (0.836 ± 0.017), compared to currently depressed (0.781 ± 0.018, p = 0.006), remitted (0.776 ± 0.014, p < 0.001), and never-depressed individuals (0.773 ± 0.016, p < 0.001). Moreover, remitted individuals who experienced depressive symptom recurrence during antidepressant tapering exhibited a larger α during sleep after the symptom onset as compared to before (after: α = 0.703 ± 0.022; before: α = 0.680 ± 0.022; p < 0.001).Conclusions: These findings suggest a link between fractal motor activity patterns during sleep and depressive symptom recurrence in remitted individuals and those with recent depression.


  • Open Access

    A pilot randomised controlled trial of a multidomain lifestyle intervention for outpatients with chronic or severe mental illness

    by Charlie Schillemans, Harm Jan Rogier Hoenders, Esther Steffek, Casper Johannes Albers, Sanne Henrieke Booij, Stynke Castelein


  • Open Access

    The associations between daily reports of loneliness and psychotic experiences in the early risk stages for psychosis

    by Esdras Raposo‐Almeida, Sara van der Tuin, Merel K. Muller, David van Den Berg, Yuan‐Pang Wang, Wim Veling, Sanne H. Booij, Johanna T. W. Wigman

    Aim: Bi‐directional associations between loneliness and psychotic experiences (PEs) have been reported, but the mechanisms underlying these associations are unknown. This study aims to explore associations between daily reports of loneliness and PEs, and test differences in this association across young adult individuals at different levels of risk for psychosis. Methods: We analysed 90‐day diary data on loneliness and PEs from N = 96 participants (mean age 24.7, range 18–35, 77% female) divided into 4 subgroups, each indexing increased levels of risk for psychosis according to the clinical staging model: ‘psychometric’ ( n = 25), ‘low’ ( n = 27), ‘mild’ ( n = 24), and ‘ultra‐high’( n = 20) risk. Multilevel vector autoregressive models examined within‐day (contemporaneous) and between‐day (temporal) associations between loneliness and PEs for the total sample. Next, these associations were compared across subgroups. Results: Loneliness and PEs were significantly associated contemporaneously (partial correlation B = 0.14) but not temporally. Subgroup membership moderated both contemporaneous and temporal associations. The contemporaneous association between loneliness and PEs was stronger in the low‐risk subgroup compared to the mild‐risk ( B = −0.35, p < .01) and ultra‐high‐risk ( B = −0.36, p < .01) subgroups. The temporal association between loneliness on the previous day and PEs on the current day was stronger in mild‐risk subgroup compared to the ultra‐high‐risk subgroup ( B = −0.03, p = .03). After adjusting for multiple testing, only the contemporaneous—but not the temporal—associations remained statistically significant. Conclusions: Loneliness is associated with PEs in individuals at risk for psychosis, particularly in those with low to mild symptoms. Our findings tentatively suggest that especially individuals with low expressions of PEs may be more sensitive to social context, but future studies are needed to replicate and further unravel the potentially stage‐specific interplay between social context and PEs.


  • Open Access

    The added value of daily diary data in 1- and 3-year prediction of psychopathology and psychotic experiences in individuals at risk for psychosis

    by S. van der Tuin, S.H. Booij, M.K. Muller, D. van Den Berg, A.J. Oldehinkel, J.T.W. Wigman


  • Open Access

    Transdiagnostic factors predicting the 2-year disability outcome in patients with anxiety and depressive disorders

    by G. Margaret Ruitenberg, S. H. Sanne Booij, N. M. Neeltje Batelaan, A. W. Adriaan Hoogendoorn, H. A. Henny Visser

    Background: Both anxiety and depressive disorders are associated with significant long-term disability. Since experienced impairments vary between patients independent of diagnosis and disease severity, identifying transdiagnostic factors that predict the course of disability may provide new targets to reduce disability. This study examines transdiagnostic factors predicting the 2-year disability outcome in patients with anxiety and/or depressive disorders (ADD), focusing on potentially malleable factors. Methods: Six hundred fifteen participants with a current diagnosis of ADD from the Netherlands Study of Depression and Anxiety (NESDA) were included. Disability was assessed at baseline and after 2 years of follow-up, using the 32-item WHODAS II questionnaire. Transdiagnostic predictors of 2-year disability outcome were identified using linear regression analysis. Results: In univariable analyses, transdiagnostic factors associated with the 2-year disability outcome were locus of control (standardized β = -0.116, p = 0.011), extraversion (standardized β = -0.123 p = 0.004) and experiential avoidance (standardized β = 0.139, p = 0.001). In multivariable analysis, extraversion had a unique predictive value (standardized β = -0.143 p = 0.003). A combination of sociodemographic, clinical and transdiagnostic variables resulted in an explained variance (R2) of 0.090). The explained variance of a combination of transdiagnostic factors was 0.050. Conclusion: The studied transdiagnostic variables explain a small but unique part of variability in the 2-year disability outcome. Extraversion is the only malleable transdiagnostic factor predictive of the course of disability independent of other variables. Due to the small contribution to the variance in the disability outcome, the clinical relevance of targeting extraversion seems limited. However, its predictive value is comparable to that of accepted disease severity measures, supporting the importance of looking beyond using disease severity measures as predictors. Furthermore, studies including extraversion in combination with other transdiagnostic and environmental factors may elucidate the unexplained part of variability of the course of disability in patients with ADD.